Xinming Zhao

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Contrast Enhanced

Diffuse Large B Cell Lymphoma

Positron Emission Tomography

Top Venues

Cancer biotherapy & radiopharmaceuticals

EJNMMI research

International journal of radiation biology

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaojing Jiang, Tianyue Li, Jianfang Wang, Zhaoqi Zhang, Xiaolin Chen, Jingmian Zhang, Xinming Zhao
Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using 18 F-FDG Positron Emission Tomography/Computed Tomography-Based Radiomics: A Pilot Study. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Yunuan Liu, Jiangyang Pan, Fenglian Jing, Xiaolin Chen, Xinming Zhao, Jingmian Zhang, Zhaoqi Zhang, Jianfang Wang, Meng Dai, Na Wang, Xiujuan Zhao, Jingya Han, Tingting Wang, Xiaoshan Chen, Huiqing Yuan
Comparison of 68 Ga-FAPI-04 and 18 F-FDG PET/CT in diagnosing ovarian cancer. Abdominal radiology (New York) (2024)
Fenglian Jing, Xinchao Zhang, Yunuan Liu, Xiaolin Chen, Xinming Zhao, Xiaoshan Chen, Huiqing Yuan, Meng Dai, Na Wang, Jingya Han, Jingmian Zhang
Baseline 18 F-FDG PET Radiomics Predicting Therapeutic Efficacy of Diffuse Large B-Cell Lymphoma after R-CHOP (-Like) Therapy. Cancer biotherapy & radiopharmaceuticals (2024)
Tianyue Li, Yunuan Liu, Meng Dai, Xiujuan Zhao, Jingya Han, Zhaoqi Zhang, Fenglian Jing, Weiwei Tian, Jingmian Zhang, Xinming Zhao, Jianfang Wang, Tiancheng Hao, Tingting Wang
Value of Semi-Quantitative Parameters of 68 Ga-FAPI-04 PET/CT in Primary Malignant and Benign Diseases: A Comparison with 18 F-FDG. Cancer biotherapy & radiopharmaceuticals (2024)
Fenglian Jing, Xinchao Zhang, Yunuan Liu, Xiaolin Chen, Jianqiang Zhao, Xinming Zhao, Xiaoshan Chen, Huiqing Yuan, Meng Dai, Na Wang, Zhaoqi Zhang, Jingmian Zhang
Baseline 18 F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma with extranodal involvement. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Xiaojing Jiang, Tianyue Li, Jianfang Wang, Zhaoqi Zhang, Xiaolin Chen, Jingmian Zhang, Xinming Zhao
Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using 18 F-FDG Positron Emission Tomography/Computed Tomography-Based Radiomics: A Pilot Study. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Xiaojing Jiang, Tianyue Li, Jianfang Wang, Zhaoqi Zhang, Xiaolin Chen, Jingmian Zhang, Xinming Zhao
Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using 18 F-FDG Positron Emission Tomography/Computed Tomography-Based Radiomics: A Pilot Study. Cancer biotherapy & radiopharmaceuticals (2024)
Huiqing Yuan, Xiaoshan Chen, Mengmeng Zhao, Xinming Zhao, Xiaolin Chen, Jingya Han, Zhaoqi Zhang, Jingmian Zhang, Jianfang Wang, Meng Dai, Yunuan Liu
Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [ 68 Ga]Ga-DOTA-FGFR1-Peptide. Cancer biotherapy & radiopharmaceuticals (2024)
Xiaojing Jiang, Tianyue Li, Jianfang Wang, Zhaoqi Zhang, Xiaolin Chen, Jingmian Zhang, Xinming Zhao
Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using 18 F-FDG Positron Emission Tomography/Computed Tomography-Based Radiomics: A Pilot Study. Cancer biotherapy & radiopharmaceuticals 39 (3) (2024)
Na Wang, Meng Dai, Fenglian Jing, Yunuan Liu, Yan Zhao, Zhaoqi Zhang, Jianfang Wang, Jingmian Zhang, Yingchen Wang, Xinming Zhao
Value of 18 F-FDG PET/CT-based radiomics features for differentiating primary lung cancer and solitary lung metastasis in patients with colorectal adenocarcinoma. International journal of radiation biology (2024)
Xiaoqian Zhao, Yan Zhao, Jingmian Zhang, Zhaoqi Zhang, Lihua Liu, Xinming Zhao
Predicting PD-L1 expression status in patients with non-small cell lung cancer using [ 18 F]FDG PET/CT radiomics. EJNMMI research 13 (1) (2023)
Xiaoqian Zhao, Yan Zhao, Jingmian Zhang, Zhaoqi Zhang, Lihua Liu, Xinming Zhao
Predicting PD-L1 expression status in patients with non-small cell lung cancer using [ 18 F]FDG PET/CT radiomics. EJNMMI research 13 (1) (2023)
Fenglian Jing, Yunuan Liu, Xinming Zhao, Na Wang, Meng Dai, Xiaolin Chen, Zhaoqi Zhang, Jingmian Zhang, Jianfang Wang, Yingchen Wang
Baseline 18 F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma. EJNMMI research 13 (1) (2023)
Xiaoqian Zhao, Yan Zhao, Jingmian Zhang, Zhaoqi Zhang, Lihua Liu, Xinming Zhao
Predicting PD-L1 expression status in patients with non-small cell lung cancer using [ 18 F]FDG PET/CT radiomics. EJNMMI research 13 (1) (2023)
Xiaoqian Zhao, Yan Zhao, Jingmian Zhang, Zhaoqi Zhang, Lihua Liu, Xinming Zhao
Predicting PD-L1 expression status in patients with non-small cell lung cancer using [ 18 F]FDG PET/CT radiomics. EJNMMI research 13 (1) (2023)
Yunuan Liu, Xiaoshan Chen, Fenglian Jing, Xinming Zhao, Zhaoqi Zhang, Jingmian Zhang, Jianfang Wang, Meng Dai, Na Wang, Tingting Wang, Xiaolin Chen
Feasibility of One-Day PET/CT Scanning Protocol with 68 Ga-DOTA-FAPI-04 and 18 F-FDG for the Detection of Ovarian Cancer Recurrence and Metastasis. Cancer biotherapy & radiopharmaceuticals (2023)
Meng Dai, Na Wang, Xinming Zhao, Jianyuan Zhang, Zhaoqi Zhang, Jingmian Zhang, Jianfang Wang, Yujing Hu, Yunuan Liu, Xiujuan Zhao, Xiaolin Chen
Value of Presurgical 18 F-FDG PET/CT Radiomics for Predicting Mediastinal Lymph Node Metastasis in Patients with Lung Adenocarcinoma. Cancer biotherapy & radiopharmaceuticals (2022)
Wei Mu, Lei Jiang, JianYuan Zhang, Yu Shi, Jhanelle E Gray, Ilke Tunali, Chao Gao, Yingying Sun, Zhenyu Zhang, Xinming Zhao, Xilin Sun, Robert James Gillies, Matthew B Schabath
Non-invasive decision support for NSCLC treatment using PET/CT radiomics. Nature communications 11 (1) (2020)
Honglei Jiao, Xinming Zhao, Jingya Han, Jingmian Zhang, Jianfang Wang
Synthesis of a novel 99mTc labeled GE11 peptide for EGFR SPECT imaging. International journal of radiation biology 96 (11) (2020)
Yujing Hu, Xinming Zhao, Jianyuan Zhang, Jingya Han, Meng Dai
Value of 18F-FDG PET/CT radiomic features to distinguish solitary lung adenocarcinoma from tuberculosis. European journal of nuclear medicine and molecular imaging 48 (1) (2020)
Jianyuan Zhang, Xinming Zhao, Yan Zhao, Jingmian Zhang, Zhaoqi Zhang, Jianfang Wang, Yingchen Wang, Meng Dai, Jingya Han
Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer. European journal of nuclear medicine and molecular imaging 47 (5) (2019)
Jingya Han, Yan Zhao, Xinming Zhao, Tuo Ma, Tiancheng Hao, Jiahui Liu, Zhaoqi Zhang, Jingmian Zhang, Jianfang Wang
Therapeutic efficacy and imaging assessment of the HER2-targeting chemotherapy drug ZHER2:V2-pemetrexed in lung adenocarcinoma Xenografts. Investigational new drugs 38 (4) (2019)